Mireia Moreno
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 02, 2025
Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice.
Journal: Cancers
Published: November 08, 2022
Exploring the Role of Galectins in Cancer : In Vitro and In Vivo Approaches.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: March 23, 2022
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis.
Journal: EBioMedicine
Published: October 11, 2021
Increased plasma levels of galectin-1 in pancreatic cancer: potential use as biomarker.
Journal: Oncotarget
Published: August 01, 2018
Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 05, 2018
The pancreatic niche inhibits the effectiveness of sunitinib treatment of pancreatic cancer.
Journal: Oncotarget
Published: January 14, 2016
Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer.
Journal: The Journal of pathology
Published: February 17, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026